Company Filing History:
1 out of 5,076 
1 out of 55 
1 out of 9 
Years Active: 2019
Title: Eric Adriaenssens: Innovator in Tissue Regeneration
Introduction
Eric Adriaenssens is a notable inventor based in Faumont, France. He has made significant contributions to the field of biotechnology, particularly in the area of tissue regeneration. His work focuses on the development of proteins that can activate the MET receptor, which plays a crucial role in cellular processes.
Latest Patents
Eric Adriaenssens holds a patent for MET receptor agonist proteins. This patent discloses proteins derived from the HGF/SF that are capable of inducing activation of the tyrosine kinase receptor MET. The patent also covers nucleic acid molecules coding for such proteins, expression vectors containing these nucleic acid molecules, host cells that harbor these expression vectors, and related compositions. This innovation has potential applications in promoting tissue regeneration.
Career Highlights
Throughout his career, Eric has worked with prestigious institutions such as the Centre National de la Recherche Scientifique and the Institut Pasteur de Lille. His experience in these organizations has allowed him to advance his research and contribute to significant scientific advancements.
Collaborations
Eric has collaborated with notable colleagues, including Jerome Vicogne and Oleg Melnyk. These partnerships have enriched his research and expanded the impact of his work in the scientific community.
Conclusion
Eric Adriaenssens is a pioneering inventor whose work on MET receptor agonist proteins holds promise for advancements in tissue regeneration. His contributions to biotechnology continue to influence the field and inspire future innovations.